Admescope Sweden

Offers standard and tailor-made metabolism studies during all phases of drug development in order to understand the drug's metabolism and whether humanmetabolites are covered in safety testing.

Through close collaboration with the customer throughout the study process, specific methods of analysis can be developedand high quality data generated. Admescope Sweden is a subsidiary of Finnish Admescope Ltd, which offers tailor-made studies in ADME-Tox. The parent company has existed since 2011 and has today customers in 25 countries.